HK1206986A1 - 流行性感冒病毒感染癥的預防‧治療劑 - Google Patents

流行性感冒病毒感染癥的預防‧治療劑

Info

Publication number
HK1206986A1
HK1206986A1 HK15107649.3A HK15107649A HK1206986A1 HK 1206986 A1 HK1206986 A1 HK 1206986A1 HK 15107649 A HK15107649 A HK 15107649A HK 1206986 A1 HK1206986 A1 HK 1206986A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
influenza virus
virus infection
infection
Prior art date
Application number
HK15107649.3A
Other languages
English (en)
Inventor
田中徹
中島元夫
高橋究
石井琢也
木戶博
千田淳司
山根彥
Original Assignee
Sbi Pharmaceuticals Co Ltd
Univ Tokushima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbi Pharmaceuticals Co Ltd, Univ Tokushima filed Critical Sbi Pharmaceuticals Co Ltd
Publication of HK1206986A1 publication Critical patent/HK1206986A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107649.3A 2012-07-19 2015-08-08 流行性感冒病毒感染癥的預防‧治療劑 HK1206986A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012160999 2012-07-19
PCT/JP2013/003486 WO2014013664A1 (ja) 2012-07-19 2013-06-03 インフルエンザウイルス感染症の予防・治療剤

Publications (1)

Publication Number Publication Date
HK1206986A1 true HK1206986A1 (zh) 2016-01-22

Family

ID=49948508

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15106311.2A HK1205688A1 (zh) 2012-07-19 2015-07-02 流行性感冒病毒感染症的預防或治療劑
HK15107649.3A HK1206986A1 (zh) 2012-07-19 2015-08-08 流行性感冒病毒感染癥的預防‧治療劑

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15106311.2A HK1205688A1 (zh) 2012-07-19 2015-07-02 流行性感冒病毒感染症的預防或治療劑

Country Status (9)

Country Link
US (1) US9351949B2 (zh)
EP (1) EP2875813B1 (zh)
JP (1) JP5920901B2 (zh)
CN (1) CN104487067B (zh)
AU (1) AU2013291455B2 (zh)
CA (1) CA2877232C (zh)
HK (2) HK1205688A1 (zh)
TW (1) TWI584805B (zh)
WO (1) WO2014013664A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016163082A1 (ja) * 2015-04-10 2016-10-13 Ｓｂｉファーマ株式会社 Ａｌａ類を含むウイルス感染症予防／治療剤
CN106581052B (zh) * 2015-04-24 2020-11-06 中国科学院上海巴斯德研究所 柠檬酸根离子和铁离子在抑制rna病毒中的应用
CN105854004A (zh) * 2016-05-05 2016-08-17 中国医学科学院病原生物学研究所 血红素在抗流感病毒中的应用
CN108014129B (zh) * 2016-11-03 2022-06-28 中国科学院上海巴斯德研究所 铁离子在抑制rna病毒中的应用
JP2019085382A (ja) * 2017-11-10 2019-06-06 ネオファーマジャパン株式会社 植物ウイルス病の予防又は治療剤
EP3960241A4 (en) 2019-04-26 2023-06-07 Neopharma Japan Co., Ltd. THERAPEUTIC AGENT FOR FLAVIVIRUS INFECTION
WO2021132626A1 (ja) * 2019-12-27 2021-07-01 国立大学法人北海道大学 豚熱の治療及び／又は予防剤
EP4140479A4 (en) * 2020-04-22 2024-05-29 Neopharma Japan Co Ltd THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)
CN115916178A (zh) * 2020-07-15 2023-04-04 日本纽翱医药股份有限公司 非洲猪瘟(African Swine Fever:ASF)的治疗剂和/或预防剂
WO2022201644A1 (ja) * 2021-03-26 2022-09-29 国立大学法人東京工業大学 Ｔｍｐｒｓｓ２発現抑制用医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895786A (en) 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
JP4510222B2 (ja) * 2000-04-26 2010-07-21 三菱化学メディエンス株式会社 細菌の鑑別方法
KR100365151B1 (ko) 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
JP4754731B2 (ja) * 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
JP4814568B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 免疫機能向上剤
CA2579032C (en) * 2004-09-02 2011-11-29 Cosmo Oil Co., Ltd. Use of an .delta.-amino acid as thymocyte growth agent
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
JP5098051B2 (ja) 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
JP5496881B2 (ja) 2008-05-14 2014-05-21 Ｓｂｉファーマ株式会社 男性不妊治療剤
KR101322259B1 (ko) 2008-10-27 2013-10-28 에스비아이 파마 가부시키가이샤 5-아미노레불린산 혹은 그의 유도체, 또는 그들 염을 유효성분으로 하는 성인병의 예방·개선제
JP2009143939A (ja) 2009-01-27 2009-07-02 Tsujido Chemical Corp 治療剤
CN101874795A (zh) 2009-04-28 2010-11-03 上海复旦张江生物医药股份有限公司 5-氨基酮戊酸在制备治疗hpv病毒感染的药物的用途
JP5611548B2 (ja) 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
CN102461733A (zh) 2010-11-05 2012-05-23 天津瑞普生物技术股份有限公司 一种含有低聚木糖的组合物
JP5904518B2 (ja) 2012-07-13 2016-04-13 Ｓｂｉファーマ株式会社 免疫寛容誘導剤

Also Published As

Publication number Publication date
EP2875813B1 (en) 2018-04-18
EP2875813A1 (en) 2015-05-27
WO2014013664A1 (ja) 2014-01-23
CA2877232C (en) 2017-08-22
CA2877232A1 (en) 2014-01-23
JPWO2014013664A1 (ja) 2016-06-30
TW201412306A (zh) 2014-04-01
AU2013291455A1 (en) 2015-01-29
US20150164838A1 (en) 2015-06-18
AU2013291455B2 (en) 2016-07-21
CN104487067B (zh) 2017-09-01
EP2875813A4 (en) 2016-04-20
TWI584805B (zh) 2017-06-01
US9351949B2 (en) 2016-05-31
JP5920901B2 (ja) 2016-05-18
CN104487067A (zh) 2015-04-01
HK1205688A1 (zh) 2015-12-24

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
IL262123A (en) Influenza virus vaccines and their uses
HK1206986A1 (zh) 流行性感冒病毒感染癥的預防‧治療劑
HK1209646A1 (zh) 經鼻流感疫苗組合物
HK1199211A1 (zh) 流感病毒疫苗及其用途
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1212905A1 (zh) 用於防止登革熱病毒感染的疫苗組合物
HK1208628A1 (zh) 用於肝臟疾病的預防劑或治療劑
IL229307A0 (en) Inactivated dengue virus vaccine
HK1207970A1 (zh) 流感中和藥劑
ZA201300395B (en) Influenza vaccine
HK1213816A1 (zh) 治療 型肝炎病毒感染的醫藥組合物
ZA201501601B (en) Virus purification and formulation process
HK1201283A1 (zh) 丙型流感病毒和疫苗
EP2822599A4 (en) VACCINE
HK1209140A1 (zh) 牛流感病毒組合物
EP3000478A4 (en) Therapeutic or prophylactic agent for immunodeficiency virus infection
GB201215184D0 (en) Therapeutic virus
HK1205680A1 (zh) 用於治療丙型肝炎病毒的藥劑
EP2749287A4 (en) INHIBITOR OF INFLUENZA VIRUS INFECTION
AU2012905097A0 (en) Agents and methods for inhibiting virus infection